Navigate to
540 Results for GLP-1 Pipeline Update
-
*Orphan drug status intravenous (IV); Prescription Drug User Fee Act (PDUFA) Cell therapy: Aims to replace or repair damaged cells through transplantation of healthy ones Editorial team Editor's...
-
Specialty Pharmacy Continuum
PA Sub-Categories: GLP-1 Prime Article: In the News -
Prime study finds individuals enrolled in the program for six months who took GLP-1 drugs for obesity lost an average of 22.5 pounds, and 95% of patients remained on GLP-1 therapy
Prime Article: Research & Publications PA Research & Publications: Research posters & abstracts -
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News